Is Rivian the Next Tesla?

Is Euroland the next Argentina?

Pharmacogenomics: What is Next?

Pharmacogenomics is moving from a candidate gene strategy to large scale approaches. This is in line with the new paradigm of linking a trait to (a) pathway(s) rather than to single genes. In addition, breakthroughs in genomics offer a non-a priori assessment of implicated genes, expanding the possibilities in pharmacogenomics research. In this review, we discuss the pros and cons of new concep...

Is Brazil Next?

© Institute for International Economics. All rights reserved. John Williamson, senior fellow since 1981, was on leave as chief economist for South Asia at the World Bank during 1996-99. He was a professor of economics at Pontifícia Universidade Católica do Rio de Janeiro (1978-81), University of Warwick (1970-77), Massachusetts Institute of Technology (1967, 1980), University of York (1963-68),...

Is Australia prepared for the next pandemic?

nfectious diseases continue to threaten global health security, despite decades of advances in hygiene, Ivaccination and antimicrobial therapies. Population growth, widespread international travel and trade, political instability and climate change have caused rapid changes in human populations, wildlife and agriculture, in turn increasing the risk of infection transmission within and between c...

Next-Generation Sequencing: The Race Is On

The $1000 genome may still be years away, but with the arrival of next-generation sequencing (NGS) technologies that are much faster and cheaper than the traditional Sanger method, large-scale sequencing of hundreds or even thousands of human genomes is fast becoming reality.